Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: Botulinum toxin type A
Trade Name: Botox
Date Designated: 08/20/1986
Orphan Designation: Treatment of cervical dystonia.
Orphan Designation Status: Designated/Approved
Allergan, Inc.
2525 Dupont Drive
P.O. Box 19534
Irvine, California 92623
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: Botulinum toxin type A
Trade Name: Botox
Marketing Approval Date: 12/21/2000
Approved Labeled Indication: Treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia.
Exclusivity End Date: 12/21/2007 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.
-
-